GSK is one of the world’s leading research-based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
The GSK team research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
GSK manufactures a number of vaccines worldwide, some of which are on the UK national immunisation schedule.
Over the past decade, GSK has donated a whopping £214,100 to Meningitis Now awareness projects. This includes the delivery of our MARM initiative, to increase people’s knowledge of meningitis in healthcare and educational settings, the delivery of more than 1 million of our life saving meningitis signs and symptoms cards within community groups across the UK and funding to support more than 100 young people, through our Believe & Achieve Programme.
This year, GSK are funding the printing costs for thousands of Meningitis Now signs and symptoms cards. These cards are vital to our awareness raising activities and are distributed to new parents, childcare nurseries, schools, businesses, healthcare organisations and at our events.
Knowing the signs and symptoms of meningitis and septicaemia and what action to take if you suspect the disease really can save lives. During our 37-year history, we have distributed more than 23 million cards. The latest donation from GSK ensures that we will reach even more people with this potentially critical information.
Mark Jefferies, Corporate Partnerships Manager, said
“We are so pleased to be able to use this latest donation from GSK towards the printing costs of our signs and symptoms cards. Raising awareness of this disease has remained a core objective of Meningitis Now throughout our existence. We take enormous pride in the way that partners such as GSK continue to support our work.”